These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16258020)

  • 61. Isothiocyanate-substituted benzyl ether opioid receptor ligands derived from 6 beta-naltrexol.
    Davis RD; Nelson WL
    J Med Chem; 1995 Feb; 38(3):570-9. PubMed ID: 7853350
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sex differences in the effectiveness of buprenorphine to decrease rates of responding in rhesus monkeys.
    Schwienteck KL; Negus SS; Banks ML
    Behav Pharmacol; 2019 Jun; 30(4):358-362. PubMed ID: 30212383
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists.
    Yuan Y; Stevens DL; Braithwaite A; Scoggins KL; Bilsky EJ; Akbarali HI; Dewey WL; Zhang Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4731-4. PubMed ID: 22683223
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol.
    Nelson TD; Davis RD; Nelson WL
    J Med Chem; 1994 Dec; 37(25):4270-7. PubMed ID: 7996538
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice (38558).
    Fujimoto JM; Roerig S; Wang RI; Chatterjie N; Inturrisi CE
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):443-8. PubMed ID: 1168347
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts.
    Ferrari A; Bertolotti M; Dell'Utri A; Avico U; Sternieri E
    Drug Alcohol Depend; 1998 Nov; 52(3):211-20. PubMed ID: 9839147
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys.
    Sell SL; McMahon LR; Koek W; France CP
    Behav Pharmacol; 2005 Feb; 16(1):53-8. PubMed ID: 15706138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro metabolism and identification of human enzymes involved in the metabolism of methylnaltrexone.
    Tong Z; Chandrasekaran A; Li H; Rotshteyn Y; Erve JC; Demaio W; Talaat R; Hultin T; Scatina J
    Drug Metab Dispos; 2010 May; 38(5):801-7. PubMed ID: 20173089
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of the effects of 6-beta naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats.
    Stromberg MF; Rukstalis MR; Mackler SA; Volpicelli JR; O'Brien CP
    Pharmacol Biochem Behav; 2002 May; 72(1-2):483-90. PubMed ID: 11900823
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of naltrexone and 6-beta-naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.
    Huang W; Moody DE; Foltz RL; Walsh SL
    J Anal Toxicol; 1997; 21(4):252-7. PubMed ID: 9248940
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys.
    Young AM; Swain HH; Woods JH
    Psychopharmacology (Berl); 1981; 74(4):329-35. PubMed ID: 6794076
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice.
    Wang YS; Hung TW; Bae EK; Wu KJ; Hsieh W; Yu SJ
    CNS Neurosci Ther; 2021 Jul; 27(7):831-841. PubMed ID: 34018697
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators.
    Ma H; Obeng S; Wang H; Zheng Y; Li M; Jali AM; Stevens DL; Dewey WL; Selley DE; Zhang Y
    J Med Chem; 2019 Dec; 62(24):11399-11415. PubMed ID: 31782922
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.
    Wang H; Reinecke BA; Zhang Y
    J Comput Aided Mol Des; 2020 Aug; 34(8):879-895. PubMed ID: 32193867
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography with electrochemical detection.
    Davidson AF; Emm TA; Pieniaszek HJ
    J Pharm Biomed Anal; 1996 Sep; 14(12):1717-25. PubMed ID: 8887719
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone.
    Jiang JB; Hanson RN; Portoghese PS; Takemori AE
    J Med Chem; 1977 Aug; 20(8):1100-2. PubMed ID: 894682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantification of naltrexone and 6,beta-naltrexol in plasma and milk using gas chromatography-mass spectrometry. Application to studies in the lactating sheep.
    Chan CF; Chiswell GM; Bencini R; Hackett LP; Dusci LJ; Ilett KF
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(1):85-92. PubMed ID: 11585135
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Naltrexone metabolism and sustained release following administration of an insoluble complex to rhesus monkeys and guinea-pigs.
    Macgregor TR; Drum MA; Harrigan SE; Wiley JN; Reuning RH
    J Pharm Pharmacol; 1983 Jan; 35(1):38-42. PubMed ID: 6131962
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone.
    Li JG; Chen C; Yin J; Rice K; Zhang Y; Matecka D; de Riel JK; DesJarlais RL; Liu-Chen LY
    Life Sci; 1999; 65(2):175-85. PubMed ID: 10416823
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists.
    Chambers DR; Sulima A; Luo D; Prisinzano TE; Goldberg A; Xie B; Shi L; Paronis CA; Bergman J; Nassehi N; Selley DE; Imler GH; Jacobson AE; Rice KC
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.